San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...

A patient with acute myeloid leukemia received a bone marrow transplant from a deceased donor, achieved engraftment, and has ...

Thanks to Joanna from Poland, I have no measurable leukemia. Getting college-age kids to join the bone-marrow donor registry ...

Syndax (SNDX) announced positive topline results from the relapsed or refractory mutant NPM1 – mNPM1 – acute myeloid leukemia ...

The study is testing the drug in certain patients with relapsed or refractory acute myeloid leukemia (AML ... with nearly one ...

Graft-versus-host disease prophylaxis using posttransplant cyclophosphamide remains a valid option for patients with ...

FDA approves Autolus Therapeutics' Aucatzyl for adults with relapsed or refractory B-cell precursor acute lymphoblastic ...

Life was good for Betsy Ehrenberg. It was 2017, and she was 68, a partner at Boston law firm Pyle Rome Ehrenberg PC. She represented unions in collective bargaining matters and workers who’d ...

On Tuesday, Syndax Pharmaceuticals Inc (NASDAQ:SNDX) revealed topline results from the relapsed or refractory (R/R) mutant ...

Researchers have identified a key weakness in acute myeloid leukemia ... Experiments in cell cultures, conducted by the ...

Mizuho Securities analyst Salim Syed has maintained their bullish stance on SNDX stock, giving a Buy rating yesterday. Salim Syed has given ...

Third Quarter 2024 Financial Results About Briquilimab Briquilimab is a targeted aglycosylated monoclonal antibody that blocks stem ... (SCID), acute myeloid leukemia (AML), myelodysplastic syndromes ...